Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertil Jonsson

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Ergonomics|September 27, 2007
Seat adjustment--capacity and repeatability among occupants in a modern carBertil Jonsson, Hans Stenlund, Mats Y Svensson, et al.
Traffic Injury Prevention|March 17, 2007
Backset and cervical retraction capacity among occupants in a modern carBertil Jonsson, Hans Stenlund, Mats Y Svensson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2011
The European Medicines Agency: an overview of its mission, responsibilities, and recent initiatives in cancer drug regulationFrancesco Pignatti, Iordanis Gravanis, Ralf Herold, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 10, 2011
Qualification opinion of novel methodologies in the predementia stage of Alzheimer's disease: cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden--regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trialsMaria Isaac, Spiros Vamvakas, Eric Abadie, et al.
Lancet (London, England)|April 20, 2002
Placebo-controlled trials and the Declaration of HelsinkiJohn A Lewis, Bertil Jonsson, Gottfried Kreutz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
Cancer drug development and the evolving regulatory framework for companion diagnostics in the European unionFrancesco Pignatti, Falk Ehmann, Robert Hemmings, et al.
Medical Oncology (Northwood, London, England)|September 18, 2007
Erythropoietin therapy and cancer related anaemia: updated Swedish recommendationsJane Ahlqvist-Rastad, Maria Albertsson, Jonas Bergh, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2013
The European Medicines Agency review of vemurafenib (Zelboraf®) for the treatment of adult patients with BRAF V600 mutation-positive unresectable or metastatic melanoma: summary of the scientific assessment of the Committee for Medicinal Products for Human UseSilvy da Rocha Dias, Tomas Salmonson, Barbara van Zwieten-Boot, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Ergonomics|September 27, 2007
Seat adjustment--capacity and repeatability among occupants in a modern carBertil Jonsson, Hans Stenlund, Mats Y Svensson, et al.
Traffic Injury Prevention|March 17, 2007
Backset and cervical retraction capacity among occupants in a modern carBertil Jonsson, Hans Stenlund, Mats Y Svensson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2011
The European Medicines Agency: an overview of its mission, responsibilities, and recent initiatives in cancer drug regulationFrancesco Pignatti, Iordanis Gravanis, Ralf Herold, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 10, 2011
Qualification opinion of novel methodologies in the predementia stage of Alzheimer's disease: cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden--regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trialsMaria Isaac, Spiros Vamvakas, Eric Abadie, et al.
Lancet (London, England)|April 20, 2002
Placebo-controlled trials and the Declaration of HelsinkiJohn A Lewis, Bertil Jonsson, Gottfried Kreutz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
Cancer drug development and the evolving regulatory framework for companion diagnostics in the European unionFrancesco Pignatti, Falk Ehmann, Robert Hemmings, et al.
Medical Oncology (Northwood, London, England)|September 18, 2007
Erythropoietin therapy and cancer related anaemia: updated Swedish recommendationsJane Ahlqvist-Rastad, Maria Albertsson, Jonas Bergh, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2013
The European Medicines Agency review of vemurafenib (Zelboraf®) for the treatment of adult patients with BRAF V600 mutation-positive unresectable or metastatic melanoma: summary of the scientific assessment of the Committee for Medicinal Products for Human UseSilvy da Rocha Dias, Tomas Salmonson, Barbara van Zwieten-Boot, et al.
Pageof 2